In the same study, IDO2 was detected by immunohistochemistry in the tumor cells from 12 out of 12 pancreatic carcinoma samples, but not in normal pancreatic tissue, using an anti-IDO2 polyclonal antibody. The gene discussed is IDO2; the disease is exocrine pancreatic carcinoma.